ADMA Biologics (ADMA) Announces Proposed $50M Stock Offering at $1/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- ICC sets July 24 vote on whether to remove chief prosecutor Karim Khan, WSJ reports
After-Hours Stock Movers 10/20: (CSX) (THC) (CNI) Higher; (ADMA) (LRCX) (AMAT) Lower (more...)
October 20, 2021 5:51 PM EDTAfter-Hours Stock Movers:
ADMA Biologics, Inc. (Nasdaq: ADMA) 6.3% LOWER; announced that it intends to offer shares of its common stock for sale in an underwritten public offering.
ADMA Biologics (ADMA) Announces Proposed Public Offering of Common Stock
October 20, 2021 4:02 PM EDTADMA Biologics, Inc. (Nasdaq: ADMA) (ADMA or the Company), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that it intends to offer shares of its common stock for sale in an underwritten public offering. The Company intends to grant the underwriters of... More
